Mahindra Group registers interest to seek Covid-19 vaccines for employees

Diversified Mahindra Group on Friday said it has registered interest to seek COVID-19 vaccines for its employees, as per priorities and sequence to be specified by the government.

Mahindra
Press Trust of India New Delhi
1 min read Last Updated : Jan 16 2021 | 12:12 AM IST

Diversified Mahindra Group on Friday said it has registered interest to seek COVID-19 vaccines for its employees, as per priorities and sequence to be specified by the government.

The farm equipment-to-aerospace conglomerate said it would take the responsibility for the inoculation of its employees rather than have the government subsidise them.

"We have registered our interest to seek vaccines for our employees, in accordance with the priorities and sequence to be specified by the government," a Mahindra Group spokesperson said in a statement.

The spokesperson further said, "We believe it is our duty to take responsibility for the inoculation of our employees, rather than have the government subsidise them."

India is all set to roll out the world's biggest vaccination programme on Saturday with over 3 lakh healthcare workers to be inoculated on the first day of the much-anticipated drive against coronavirus.

The vaccination drive has been planned in a phased manner, identifying priority groups. Healthcare workers, both in government and private sectors including ICDS (Integrated Child Development Services) workers, will receive the vaccine during this phase, according to the health ministry.

Mahindra Group has presence in over 100 countries, employing over 2.5 lakh people.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Mahindra GroupCoronavirus Vaccineemployees

First Published: Jan 16 2021 | 12:01 AM IST

Next Story